VoyForums
[ Show ]
Support VoyForums
[ Shrink ]
VoyForums Announcement: Programming and providing support for this service has been a labor of love since 1997. We are one of the few services online who values our users' privacy, and have never sold your information. We have even fought hard to defend your privacy in legal cases; however, we've done it with almost no financial support -- paying out of pocket to continue providing the service. Due to the issues imposed on us by advertisers, we also stopped hosting most ads on the forums many years ago. We hope you appreciate our efforts.

Show your support by donating any amount. (Note: We are still technically a for-profit company, so your contribution is not tax-deductible.) PayPal Acct: Feedback:

Donate to VoyForums (PayPal):

Login ] [ Contact Forum Admin ] [ Main index ] [ Post a new message ] [ Search | Check update time | Archives: 1234567[8] ]


[ Next Thread | Previous Thread | Next Message | Previous Message ]

Date Posted: 19:17:00 09/16/06 Sat
Author: Products - Malaysia (Products - Malaysia)
Subject: Daiichi Pharmaceutical Asia Ltd.
In reply to: Corporate Conduct Guidelines 's message, "No Sense of SHAME - No Bloody CONSCIENCE" on 19:15:56 09/16/06 Sat

An oral quinolone preparation with 99% bioavailability containing levofloxacin, with a two-fold stronger activity than ofloxacin and antibacterial activity against a wide range of Gram-positive and Gram-negative bacteria. The adult daily dosage can be given from 200 mg to 600 mg in 2 or 3 divided doses.

Detailed Product Information >>





Cravit® is a synthetic antibacterial agent containing levofloxacin, a broad-spectrum fluoroquinolone effective against a wide range of Gram-positive and Gram-negative pathogens. It is indicated for acute maxillary sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, uncomplicated skin and skin-structure infections, complicated urinary tract infections, and acute pyelonephritis. Cravit i.v. 500 mg is a ready-to-use solution containing 500 mg of levofloxacin/100 mL. It should be administered intravenously by slow infusion over a period of not less than 60 minutes every 24 hours.

Detailed Product Information >>




Cravit® is a synthetic antibacterial agent containing levofloxacin, a broad-spectrum fluoroquinolone effective against a wide range of Gram-positive and Gram-negative pathogens. It is indicated for acute maxillary sinusitis, acute exacerbation of chronic bronchitis, community-acquired pneumonia, uncomplicated skin and skin-structure infections, complicated urinary tract infections, and acute pyelonephritis. Each film-coated Cravit® tablet contains 250 mg or 500 mg of levofloxacin. The recommended oral dosage is one tablet every 24 hours.

Detailed Product Information >>





An quinolone solution containing ofloxacin (200 mg/100 mL vial). It has a broad range of antibacterial activity against various Gram-positive and Gram-negative bacteria. The adult daily dose is 100-400 mg, to a maximum of
800 mg.

Detailed Product Information >>



An oral quinolone preparation containing ofloxacin, an antibacterial agent with a broad-spectrum activity against various Gram-positive and Gram-negative bacteria. The adult daily dose is 300 mg to 600 mg in 2 or 3 divided doses. Tarivid Tablets are available in 100 mg and 200 mg units.

Detailed Product Information >>



A quinolone ear solution containing ofloxacin (0.3%, 3 mg/mL), a broad-spectrum antibacterial agent indicated for Gram-positive and Gram-negative otitis media and otitis externa. The adult dose is 6-10 drops twice daily.

Detailed Product Information >>





An IV preparation of tranexamic acid (5% or 10% w/v solution) indicated in haemorrhagic, allergic and inflammatory conditions involving hyperfibrinolysis, such as abnormal bleeding in surgery, O&G, urology, or erythema. The adult daily dosage is 250-500 mg in 1-2 injections, or 500-2500 mg by IV drip infusion during and after surgery.

Detailed Product Information >>



An oral preparation of tranexamic acid (250 mg/cap), indicated in haemorrhagic, allergic and inflammatory conditions involving hyperfibrinolysis, such as abnormal bleeding in surgery, O&G, urology, or erythema. The adult daily dosage is 3-8 capsules in 3 or 4 portions.

Detailed Product Information >>








Copyright © 2006 Daiichi Pharmaceutical Asia Ltd. All Rights Reserved. | Disclaimer | Privacy Policy

Website - http://www.dpa.com.hk/p_ma.aspx?pageid=product

[ Next Thread | Previous Thread | Next Message | Previous Message ]

[ Contact Forum Admin ]


Forum timezone: GMT-8
VF Version: 3.00b, ConfDB:
Before posting please read our privacy policy.
VoyForums(tm) is a Free Service from Voyager Info-Systems.
Copyright © 1998-2019 Voyager Info-Systems. All Rights Reserved.